Product NDC: | 55390-208 |
Proprietary Name: | Epirubicin hydrochloride |
Non Proprietary Name: | Epirubicin hydrochloride |
Active Ingredient(s): | 2 mg/mL & nbsp; Epirubicin hydrochloride |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-208 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065289 |
Marketing Category: | ANDA |
Start Marketing Date: | 20070807 |
Package NDC: | 55390-208-01 |
Package Description: | 1 VIAL, PLASTIC in 1 BOX (55390-208-01) > 100 mL in 1 VIAL, PLASTIC |
NDC Code | 55390-208-01 |
Proprietary Name | Epirubicin hydrochloride |
Package Description | 1 VIAL, PLASTIC in 1 BOX (55390-208-01) > 100 mL in 1 VIAL, PLASTIC |
Product NDC | 55390-208 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Epirubicin hydrochloride |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20070807 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | EPIRUBICIN HYDROCHLORIDE |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] |